BioSpace News Archive

Tetra Therapeutics, a Shionogi Group Company, focused on the development of compounds for the treatment of brain disorders associated with cognitive and memory deficits, today announced the initiation of three Phase 2b/3 clinical studies of the investigational drug BPN14770 (zatolmilast) as a potential treatment for Fragile X Syndrome (FXS), the most common genetic form of autism.

Varex Imaging Corporation announced that it will report unaudited financial results for the third quarter of fiscal year 2022 following the close of regular trading on Tuesday, August 2, 2022.

IdentifySensors Biologics, has partnered with Jabil Inc. (NYSE: JBL), a global manufacturing solutions company, to develop processes for reliable robust manufacturing of portable devices that rapidly detect a wide range of infections at the molecular level with accuracy that is superior to PCR testing.

Global DNA methylation market size reached USD 7.79 billion in 2021 and is expected to register a revenue CAGR of 15.9% during the forecast period, according to latest analysis by Emergen Research.

The global concierge medicine market size was USD 10.8 Billion in 2021 and is expected to register a revenue CAGR of 5.9% during the forecast period, according to latest analysis by Emergen Research.

The global nebulizers market size was USD 1.12 Billion in 2021 and is expected to register a revenue CAGR of 7.6% during the forecast period, according to latest analysis by Emergen Research.

The global microarray market size was USD 3.99 Billion in 2021 and is expected to register a revenue CAGR of 8.31% during the forecast period, according to latest analysis by Emergen Research.

Endogena Therapeutics Inc. announced today that the first patient has been treated in a phase 1/2a clinical study of its lead product, EA-2353, a photoreceptor regeneration treatment for retinitis pigmentosa (RP).

Braintale, a medtech deciphering white matter, spin off from the Paris Greater Hospitals has been selected for an oral presentation of its abstract during the annual meeting of the European Society of Radiology held in Vienna from July 13th to July 17th 2022, demonstrating the technical advances of its digital biomarker platform and its usage in clinical settings.

The global Adenosine Triphosphate (ATP) Test Kit market size is estimated to be worth US$ 196.5 million in 2021 and is forecast to a readjusted size of US$ 359.4 million by 2030 with a CAGR of 8.9% during the forecast period 2022-2030.